Is a
Acquisition attributes
Acquired Company
Acquirer
Acquisition Amount (USD)
600,000,000
Date Announced
August 8, 2019
BlueRocks Therapeutics was acquired by Bayed for a reported total of $600 million. The agreement between Bayer and BlueRock detailed an upfront payment of $240 million with $360 million in milestone payments over time.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
